At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Director, Head of Anesthesiology and Critical Care, Principal Investigator, Professor
In Brief
A clinical study evaluating Dobutamine and Norepinephrine for Patients With Septic Shock and 2 related conditions. Completed, enrolled 584 participants across 1 site.
Detailed Summary
Septic shock is the last and most severe stage of sepsis and is defined by extremely low blood pressure, despite lots of intravenous fluids. The incidence of septic shock related cardiomyopathy was 10% to 70%. Besides, general anesthesia will inhibit the sympathetic nervous system, reduce myocardial contractility and aggravate cardiac dysfunction. No randomized controlled trials have yet explore the effects of dobutamine on clinical outcomes for patients with septic shock undergoing surgery under general anesthesia.
Study Details
Timeline
Interventions
Patients with septic shock in Dobutamine group will be initiated on Dobutamine at 5 mcg/kg/min when electrocardiogram, invasive blood pressure, and oxygen saturation were monitored.
Norepinephrine was titrated to maintain a mean arterial pressure at 65mmHg or more in both groups.